In which scenario would a combination of diclofenac and misoprostol be appropriate?

In which scenario would a combination of diclofenac and misoprostol be appropriate?

• A. A 6-year old with a fever likely due to a viral syndrome
• B. A 42-year old male with bursitis
• C. A 68-year old female with rheumatoid arthritis
• D. A 2-year old female with dysmenorrhea

Answer: (C)

The combination of diclofenac and misoprostol is particularly appropriate for the scenario involving a 68-year-old female with rheumatoid arthritis. Rheumatoid arthritis is an inflammatory condition that often requires long-term management with nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac to alleviate pain and reduce inflammation. However, NSAIDs can increase the risk of gastrointestinal complications, including ulcers and bleeding, especially in older adults. Misoprostol is a prostaglandin analog that helps protect the stomach lining and reduce the risk of NSAID-induced gastrointestinal damage. Therefore, using diclofenac in combination with misoprostol is beneficial in this population, as it not only addresses the arthritis pain effectively but also mitigates potential gastrointestinal risks associated with long-term NSAID therapy. In contrast, the other scenarios provided involve either younger individuals, where the use of these medications might not be indicated, or conditions where the benefits of the combination may not outweigh the risks. For instance, younger patients are often managed with different classes of medications that may be more suitable and safer for their age group and conditions.

The combination of diclofenac and misoprostol is particularly appropriate for the scenario involving a 68-year-old female with rheumatoid arthritis. Rheumatoid arthritis is an inflammatory condition that often requires long-term management with nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac to alleviate pain and reduce inflammation.

However, NSAIDs can increase the risk of gastrointestinal complications, including ulcers and bleeding, especially in older adults. Misoprostol is a prostaglandin analog that helps protect the stomach lining and reduce the risk of NSAID-induced gastrointestinal damage. Therefore, using diclofenac in combination with misoprostol is beneficial in this population, as it not only addresses the arthritis pain effectively but also mitigates potential gastrointestinal risks associated with long-term NSAID therapy.

In contrast, the other scenarios provided involve either younger individuals, where the use of these medications might not be indicated, or conditions where the benefits of the combination may not outweigh the risks. For instance, younger patients are often managed with different classes of medications that may be more suitable and safer for their age group and conditions.